NGM·Healthcare·$372M·#85 / 520 in Healthcare
CLLS Cellectis S.A.
66SOLID
CATEGORY BREAKDOWN
GROWTH90
QUALITY86
STABILITY47
VALUATION73
GOVERNANCE33
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+75.8%
90
> 50% strong
Gross Margin
Revenue retained after direct costs
86.6%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
19 months
67
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
119.5%
6
< 25% strong
Price / Sales
Market cap relative to trailing revenue
4.7x
73
< 3x strong
Rule of 40
Growth rate plus operating margin
30
66
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.0%
0
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-27.6%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CLLS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CLLS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.